Cisco
CSCO
NVIDIA
NVDA
Broadcom
AVGO
4
Taiwan Semiconductor
TSM
5
ASML Holding
ASML
US Stock MarketDetailed Quotes
PLX Protalix Biotherapeutics
- 2.580
- 0.0000.00%
Close Mar 28 16:00 ET
- 2.560
- -0.020-0.78%
Post 19:37 ET
201.32MMarket Cap64.50P/E (TTM)
2.620High2.525Low466.24KVolume2.590Open2.580Pre Close1.21MTurnover0.79%Turnover Ratio64.50P/E (Static)78.03MShares2.76052wk High4.66P/B152.61MFloat Cap0.82152wk Low--Dividend TTM59.15MShs Float1037.500Historical High--Div YieldTTM3.68%Amplitude0.700Historical Low2.589Avg Price1Lot Size
Protalix Biotherapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -18.47%53.4M | 73.74%18.22M | 73.60%17.96M | -61.59%13.47M | -60.91%3.75M | 37.48%65.49M | 21.69%10.49M | -27.06%10.35M | 300.72%35.08M | -40.39%9.59M |
| Operating revenue | -18.47%53.4M | 73.74%18.22M | 73.60%17.96M | -61.59%13.47M | -60.91%3.75M | 37.48%65.49M | 21.69%10.49M | -27.06%10.35M | 300.72%35.08M | -40.39%9.59M |
| Cost of revenue | 5.82%24.32M | -56.12%3.89M | 71.16%8.38M | 53.81%9.46M | -15.66%2.6M | 17.30%22.98M | 269.46%8.86M | -30.83%4.89M | 50.43%6.15M | -48.87%3.09M |
| Gross profit | -31.60%29.08M | 779.26%14.33M | 75.79%9.58M | -86.11%4.02M | -82.38%1.15M | 51.58%42.51M | -73.79%1.63M | -23.31%5.45M | 519.95%28.93M | -35.30%6.5M |
| Operating expense | -21.49%25.16M | -1.68%7.12M | -23.79%5.59M | -24.23%6.45M | -33.03%6M | -21.94%32.05M | -16.87%7.25M | -28.29%7.34M | -16.53%8.51M | -24.82%8.96M |
| Selling and administrative expenses | -18.49%12.19M | -27.61%3M | -29.29%2.6M | -13.57%3.48M | 0.00%3.12M | 27.73%14.96M | 33.73%4.14M | 28.86%3.67M | 54.39%4.03M | -1.24%3.12M |
| Research and development costs | -24.12%12.97M | 32.95%4.12M | -18.29%3M | -33.83%2.96M | -50.62%2.89M | -41.76%17.09M | -44.77%3.1M | -50.32%3.67M | -40.96%4.48M | -33.31%5.85M |
| Operating profit | -62.55%3.92M | 228.39%7.21M | 311.50%3.99M | -111.88%-2.43M | -97.48%-4.86M | 180.37%10.46M | -125.05%-5.62M | 39.62%-1.89M | 469.68%20.42M | -31.50%-2.46M |
| Net non-operating interest income expense | 112.51%237K | 113.19%107K | -188.10%-148K | 120.03%155K | 125.79%123K | -36.95%-1.89M | -13.43%-811K | 138.01%168K | -507.37%-774K | -14.66%-477K |
| Non-operating interest income | 1.01%1.3M | 405.41%113K | -75.96%151K | -1.69%522K | 198.26%513K | 12.22%1.29M | 43.08%-37K | 218.78%628K | -34.69%531K | -14.85%172K |
| Non-operating interest expense | -66.60%1.06M | -99.22%6K | -35.00%299K | -71.88%367K | -39.91%390K | 25.74%3.18M | 19.08%774K | -28.01%460K | 109.47%1.31M | 5.02%649K |
| Other net income (expense) | ||||||||||
| Income before tax | -51.51%4.15M | 213.85%7.32M | 323.56%3.84M | -111.56%-2.27M | -61.21%-4.73M | 159.50%8.57M | -100.19%-6.43M | 51.81%-1.72M | 468.34%19.65M | -28.43%-2.94M |
| Income tax | 381.10%1.22M | 315.18%822K | 356.39%607K | -122.40%-69K | -170.77%-138K | -52.08%254K | -172.08%-382K | 133K | 308K | 195K |
| Net income | -64.73%2.93M | 207.45%6.49M | 274.73%3.24M | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M |
| Net income continuous Operations | -64.73%2.93M | 207.45%6.49M | 274.73%3.24M | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -64.73%2.93M | 207.45%6.49M | 274.73%3.24M | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -64.73%2.93M | 207.45%6.49M | 274.73%3.24M | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M |
| Basic earnings per share | -66.67%0.04 | 190.00%0.09 | 233.33%0.04 | -110.34%-0.03 | -20.00%-0.06 | 138.71%0.12 | -42.86%-0.1 | 57.14%-0.03 | 363.64%0.29 | 0.00%-0.05 |
| Diluted earnings per share | -55.56%0.04 | 190.00%0.09 | 175.00%0.03 | -114.29%-0.03 | -20.00%-0.06 | 129.03%0.09 | -42.86%-0.1 | 42.86%-0.04 | 290.91%0.21 | 0.00%-0.05 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call